APHB:NYE-AmpliPhi Biosciences Corporation (USD)

COMMON STOCK | Other | NYE

Last Closing Price

USD 0.12

Change

0.00 (0.00)%

Market Cap

USD 0.15B

Volume

1.67M

Avg Analyst Target

N/A

Avg User Target

USD
Average Analyst Rating

N/A

Fundamental Analysis

Verdict

APHB Stock Forecast & Price:
Based on the AmpliPhi Biosciences Corporation stock forecasts from 0 analysts, the average analyst target price for AmpliPhi Biosciences Corporation is not available over the next 12 months. AmpliPhi Biosciences Corporation’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of AmpliPhi Biosciences Corporation is Very Bearish, which is based on 0 positive signals and 1 negative signals. At the last closing, AmpliPhi Biosciences Corporation’s stock price was USD 0.12. AmpliPhi Biosciences Corporation’s stock price has changed by +0.00% over the past week, +0.00% over the past month and +0.00% over the last year.

No recent analyst target price found for AmpliPhi Biosciences Corporation
No recent average analyst rating found for AmpliPhi Biosciences Corporation

About AmpliPhi Biosciences Corporation (APHB:NYE)

As of May 9, 2019, was acquired by C3J Therapeutics, Inc., in a reverse merger transaction.

Company Website : http://www.ampliphibio.com

Address : 3579 Valley Centre Drive, Suite 100 92130,San Diego,USA

Employees : 30

Fiscal Year End : December

Currency: USD

Country : USA

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2022-09-30 )

Largest Industry Peers for Other

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
BMS Bemis Company, Inc

N/A

 USD370,676,430.93B 1,000,000.00 N/A
NAO Nordic American Offshore Ltd

N/A

 USD387,070.41B N/A N/A
ITC ITC Holdings Corp

N/A

 USD3,166.52B 22.84 N/A
MSF Morgan Stanley Emerging Market..

N/A

 USD1,000.65B 24.60 N/A
HSBC-PA HSBC Holdings plc ADR A 1/40PF..

N/A

 USD513.94B 53.22 N/A
SAN-PB Banco Santander, S.A. GTD PFD ..

N/A

 USD384.67B 54.97 N/A
BAC-PW Bank of America Corporation

N/A

 USD267.69B 9.46 N/A
BAC-PY Bank of America Corporation

N/A

 USD263.53B 9.36 N/A
BEL Belmond Ltd

N/A

 USD261.58B 15.94 N/A
NEE-PR NextEra Energy, Inc

N/A

 USD103.76B 9.93 N/A

ETFs Containing APHB

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Other)		 Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 1.04% N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.04% N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 4.15% N/A N/A N/A N/A
Risk Adjusted Return 25.05% N/A N/A N/A N/A
Market Capitalization 0.15B N/A N/A N/A N/A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Other)		 Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio N/A N/A N/A N/A N/A
Price/Book Ratio N/A N/A N/A N/A N/A
Price / Cash Flow Ratio -15.88 N/A N/A N/A N/A
EV/EBITDA N/A N/A N/A N/A N/A
Management Effectiveness  
Return on Equity N/A N/A N/A N/A N/A
Return on Invested Capital -126.70% N/A N/A N/A N/A
Return on Assets N/A N/A N/A N/A N/A
Debt to Equity Ratio N/A N/A N/A N/A N/A
Technical Ratios  
Dividend Yield N/A N/A N/A N/A N/A
Short Ratio N/A N/A N/A N/A N/A
Short Percent N/A N/A N/A N/A N/A
Beta N/A N/A N/A N/A N/A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date
New Post

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment
Stock Target Advisor

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Negative cashflow

The company had negative total cash flow in the most recent four quarters.